Inna Etinberg joined OEP in 2013 and is a Principal based in New York. Ms. Etinberg has focused on investments in healthcare, industrials and business services. Ms. Etinberg is a director on the Board of Directors of AMT/Restorix, Infucare Rx, Montgomery Transport, Norit Activated Carbon, and React Health, and a Board observer at AdaptHealth. Ms. Etinberg was previously a director on the Board of Directors at PS Logistics, The Results Companies, OneLink, Simplura Health Group and was involved in OEP’s realized investments in PeroxyChem, Sonneborn, East Balt and EGS.
Prior to joining OEP, Ms. Etinberg worked in the Investment Banking division of JPMorgan in the Diversified Industries Group where she focused on the industrials, aerospace & defense and automotive sectors. Ms. Etinberg received her B.A. in Economics from Dartmouth College.